CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses
Research and development	$ 14,920	$ 11,621
General and administrative	6,304	4,899
Total operating expenses	21,224	16,520
Loss from operations	(21,224)	(16,520)
Other expense, net
Other expense, net	(129)	(147)
Total other expense, net	(129)	(147)
Net loss	(21,353)	(16,667)
Comprehensive loss	$ (21,353)	$ (16,667)
Net loss per share, basic (in dollars per share)	$ (0.78)	$ (23.53)
Net loss per share, diluted (in dollars per share)	$ (0.78)	$ (23.53)
Weighted average common shares outstanding, basic (in shares)	27,367,377	708,264
Weighted average common shares outstanding, diluted (in shares)	27,367,377	708,264